Role of Helicobacter pylori infection on nutrition and metabolism
2014-01-01 Franceschi, F.; Tortora, A.; Di Rienzo, T.; D'Angelo, G.; Ianiro, G.; Scaldaferri, F.; Gerardi, V.; Tesori, V.; Lopetuso, L. R.; Gasbarrini, A.
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
2020-01-01 Lopetuso, L. R.; Severgnini, M.; Pecere, S.; Ponziani, F. R.; Boskoski, I.; Larghi, A.; Quaranta, G.; Masucci, L.; Ianiro, G.; Camboni, T.; Gasbarrini, A.; Costamagna, G.; Consolandi, C.; Cammarota, G.
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update
2018-01-01 Holleran, G.; Scaldaferri, F.; Ianiro, G.; Lopetuso, L.; Mc Namara, D.; Mele, M. C.; Gasbarrini, A.; Cammarota, G.
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?
2013-01-01 Scaldaferri, Franco; Petito, Valentina; Papa, Alfredo; Cesari, Matteo; Arena, Vincenzo; Lopetuso, Loris Riccardo; Corbi, Maddalena; Perino, Francesca; Caldarola, Giacomo; Carbone, A; Sgambato, Alessandro; Gasbarrini, Antonio; De Simone, Clara
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists
2021-01-01 Papa, A.; Scaldaferri, F.; Vetrone, L. M.; Neri, M.; Gasbarrini, A.; Lopetuso, L. R.
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
2024-01-01 Di Vincenzo, F.; Del Gaudio, A.; Petito, V.; Lopetuso, L. R.; Scaldaferri, F.
Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure
2022-01-01 Sonyi, M.; Hammer, J.; Basilisco, G.; Belei, O.; Benninga, M. A.; Bordin, D. S.; Dumitrascu, D.; Hauser, B.; Herszenyi, L.; Lopetuso, L.; Mion, F.; Mulak, A.; Nakov, R.; Nakov, V.; Tepes, B.; Hammer, H. F.
Role of yeasts in healthy and impaired gut microbiota: the gut mycome
2014-01-01 Ianiro, Gianluca; Lopetuso, Loris Riccardo; Laterza, Lucrezia; D'Aversa, Francesca; Gigante, Giovanni; Cammarota, Giovanni; Gasbarrini, Antonio
Fecal transplantation for ulcerative colitis: current evidence and future applications
2020-01-01 Lopetuso, L. R.; Ianiro, G.; Allegretti, J. R.; Bibbò, S.; Gasbarrini, A.; Scaldaferri, F.; Cammarota, G.
Proteobacteria: A common factor in human diseases
2017-01-01 Rizzatti, G.; Lopetuso, L. R.; Gibiino, G.; Binda, C.; Gasbarrini, A.
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis
2016-01-01 Scaldaferri, F.; Pecere, S.; Petito, V.; Zambrano, D.; Fiore, L.; Lopetuso, L. R.; Schiavoni, E.; Bruno, G.; Gerardi, V.; Laterza, L.; Pizzoferrato, M.; Ianiro, G.; Stojanovic, J.; Poscia, A.; Papa, A.; Sterbini, F. P.; Sanguinetti, M.; Masucci, L.; Cammarota, G.; Gasbarrini, A.
Infliximab does not increase colonic cancer risk associated to murine chronic colitis
2016-01-01 Lopetuso, L. R.; Petito, V.; Zinicola, T.; Graziani, C.; Gerardi, V.; Arena, V.; Caristo, M. E.; Poscia, A.; Cammarota, G.; Papa, A.; Cufino, V.; Sgambato, A.; Gasbarrini, A.; Scaldaferri, F.
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period
2021-01-01 Scaldaferri, F.; Papa, A.; Napolitano, D.; Rizzatti, G.; Pistone, M. T.; Poscia, A.; Volpe, M.; Lopetuso, L. R.; Schiavoni, E.; Guidi, L.; Gaetani, E.; Holleran, G.; Cammarota, G.; Rapaccini, G.; Pugliese, D.; Ojetti, V.; Franceschi, F.; Armuzzi, A.; Gasbarrini, A.
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action
2016-01-01 Petito, V.; Lopetuso, L. R.; Arena, V.; Stigliano, E.; Boninsegna, A.; Bibbò, S.; Poscia, A.; Alfieri, S.; Rosa, F.; Amato, A.; Cammarota, G.; Papa, A.; Sgambato, A.; Gasbarrini, A.; Scaldaferri, F.
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease”
2019-01-01 Petito, V.; Fiore, L.; Lopetuso, L. R.; Scaldaferri, F.
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis
2017-01-01 Lopetuso, L. R.; Jia, R.; Wang, X. -M.; Jia, L. -G.; Petito, V.; Goodman, W. A.; Meddings, J. B.; Cominelli, F.; Reuter, B. K.; Pizarro, T. T.
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19
2020-01-01 Papa, A.; Covino, M.; Pizzolante, F.; Miele, L.; Lopetuso, L. R.; Bove, V.; Iorio, R.; Simeoni, B.; Vetrone, L. M.; Tricoli, L.; Mignini, I.; Schepis, T.; D'Alessandro, A.; Coppola, G.; Nicoletti, T.; Visconti, E.; Rapaccini, G.
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus
2021-01-01 Hammer, H. F.; Fox, M. R.; Keller, J.; Salvatore, S.; Basilisco, G.; Hammer, J.; Lopetuso, L.; Benninga, M.; Borrelli, O.; Dumitrascu, D.; Hauser, B.; Herszenyi, L.; Nakov, R.; Pohl, D.; Thapar, N.; Sonyi, M.; Altorjay, I.; Barbara, G.; Baumann-Durchschein, F.; Belei, O.; Churchev, S.; Dominguez-Munoz, E.; Effenberger, M.; Furst, S.; Gasbarrini, A.; Gotze, O.; Haas, S.; Hammer, K.; Krznaric, Z.; Leja, M.; Mion, F.; Mulak, A.; Nakov, V.; Reinisch, S.; Shvets, O.; Simren, M.; Surdea-Blaga, T.; Tepes, B.; Tornblom, H.; Tutuian, R.; Verbeke, K.; Vogelsang, H.; Vranesic-Bender, D.; Wilder-Smith, C.
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease
2018-01-01 Gaetani, E.; Zompo, F. D.; Marcantoni, M.; Gatto, I.; Giarretta, I.; Porfidia, A.; Scaldaferri, F.; Laterza, L.; Lopetuso, L.; Gasbarrini, A.; Pola, R.
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study
2019-01-01 Piscaglia, A. C.; Lopetuso, L. R.; Laterza, L.; Gerardi, V.; Sacchini, E.; Leoncini, E.; Boccia, S.; Stefanelli, M. L.; Gasbarrini, A.; Armuzzi, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Role of Helicobacter pylori infection on nutrition and metabolism | 1-gen-2014 | Franceschi, F.; Tortora, A.; Di Rienzo, T.; D'Angelo, G.; Ianiro, G.; Scaldaferri, F.; Gerardi, V.; Tesori, V.; Lopetuso, L. R.; Gasbarrini, A. | |
| Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma | 1-gen-2020 | Lopetuso, L. R.; Severgnini, M.; Pecere, S.; Ponziani, F. R.; Boskoski, I.; Larghi, A.; Quaranta, G.; Masucci, L.; Ianiro, G.; Camboni, T.; Gasbarrini, A.; Costamagna, G.; Consolandi, C.; Cammarota, G. | |
| Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update | 1-gen-2018 | Holleran, G.; Scaldaferri, F.; Ianiro, G.; Lopetuso, L.; Mc Namara, D.; Mele, M. C.; Gasbarrini, A.; Cammarota, G. | |
| Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? | 1-gen-2013 | Scaldaferri, Franco; Petito, Valentina; Papa, Alfredo; Cesari, Matteo; Arena, Vincenzo; Lopetuso, Loris Riccardo; Corbi, Maddalena; Perino, Francesca; Caldarola, Giacomo; Carbone, A; Sgambato, Alessandro; Gasbarrini, Antonio; De Simone, Clara | |
| How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists | 1-gen-2021 | Papa, A.; Scaldaferri, F.; Vetrone, L. M.; Neri, M.; Gasbarrini, A.; Lopetuso, L. R. | |
| Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review | 1-gen-2024 | Di Vincenzo, F.; Del Gaudio, A.; Petito, V.; Lopetuso, L. R.; Scaldaferri, F. | |
| Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure | 1-gen-2022 | Sonyi, M.; Hammer, J.; Basilisco, G.; Belei, O.; Benninga, M. A.; Bordin, D. S.; Dumitrascu, D.; Hauser, B.; Herszenyi, L.; Lopetuso, L.; Mion, F.; Mulak, A.; Nakov, R.; Nakov, V.; Tepes, B.; Hammer, H. F. | |
| Role of yeasts in healthy and impaired gut microbiota: the gut mycome | 1-gen-2014 | Ianiro, Gianluca; Lopetuso, Loris Riccardo; Laterza, Lucrezia; D'Aversa, Francesca; Gigante, Giovanni; Cammarota, Giovanni; Gasbarrini, Antonio | |
| Fecal transplantation for ulcerative colitis: current evidence and future applications | 1-gen-2020 | Lopetuso, L. R.; Ianiro, G.; Allegretti, J. R.; Bibbò, S.; Gasbarrini, A.; Scaldaferri, F.; Cammarota, G. | |
| Proteobacteria: A common factor in human diseases | 1-gen-2017 | Rizzatti, G.; Lopetuso, L. R.; Gibiino, G.; Binda, C.; Gasbarrini, A. | |
| Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis | 1-gen-2016 | Scaldaferri, F.; Pecere, S.; Petito, V.; Zambrano, D.; Fiore, L.; Lopetuso, L. R.; Schiavoni, E.; Bruno, G.; Gerardi, V.; Laterza, L.; Pizzoferrato, M.; Ianiro, G.; Stojanovic, J.; Poscia, A.; Papa, A.; Sterbini, F. P.; Sanguinetti, M.; Masucci, L.; Cammarota, G.; Gasbarrini, A. | |
| Infliximab does not increase colonic cancer risk associated to murine chronic colitis | 1-gen-2016 | Lopetuso, L. R.; Petito, V.; Zinicola, T.; Graziani, C.; Gerardi, V.; Arena, V.; Caristo, M. E.; Poscia, A.; Cammarota, G.; Papa, A.; Cufino, V.; Sgambato, A.; Gasbarrini, A.; Scaldaferri, F. | |
| Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period | 1-gen-2021 | Scaldaferri, F.; Papa, A.; Napolitano, D.; Rizzatti, G.; Pistone, M. T.; Poscia, A.; Volpe, M.; Lopetuso, L. R.; Schiavoni, E.; Guidi, L.; Gaetani, E.; Holleran, G.; Cammarota, G.; Rapaccini, G.; Pugliese, D.; Ojetti, V.; Franceschi, F.; Armuzzi, A.; Gasbarrini, A. | |
| Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action | 1-gen-2016 | Petito, V.; Lopetuso, L. R.; Arena, V.; Stigliano, E.; Boninsegna, A.; Bibbò, S.; Poscia, A.; Alfieri, S.; Rosa, F.; Amato, A.; Cammarota, G.; Papa, A.; Sgambato, A.; Gasbarrini, A.; Scaldaferri, F. | |
| Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” | 1-gen-2019 | Petito, V.; Fiore, L.; Lopetuso, L. R.; Scaldaferri, F. | |
| Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis | 1-gen-2017 | Lopetuso, L. R.; Jia, R.; Wang, X. -M.; Jia, L. -G.; Petito, V.; Goodman, W. A.; Meddings, J. B.; Cominelli, F.; Reuter, B. K.; Pizarro, T. T. | |
| Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 | 1-gen-2020 | Papa, A.; Covino, M.; Pizzolante, F.; Miele, L.; Lopetuso, L. R.; Bove, V.; Iorio, R.; Simeoni, B.; Vetrone, L. M.; Tricoli, L.; Mignini, I.; Schepis, T.; D'Alessandro, A.; Coppola, G.; Nicoletti, T.; Visconti, E.; Rapaccini, G. | |
| European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus | 1-gen-2021 | Hammer, H. F.; Fox, M. R.; Keller, J.; Salvatore, S.; Basilisco, G.; Hammer, J.; Lopetuso, L.; Benninga, M.; Borrelli, O.; Dumitrascu, D.; Hauser, B.; Herszenyi, L.; Nakov, R.; Pohl, D.; Thapar, N.; Sonyi, M.; Altorjay, I.; Barbara, G.; Baumann-Durchschein, F.; Belei, O.; Churchev, S.; Dominguez-Munoz, E.; Effenberger, M.; Furst, S.; Gasbarrini, A.; Gotze, O.; Haas, S.; Hammer, K.; Krznaric, Z.; Leja, M.; Mion, F.; Mulak, A.; Nakov, V.; Reinisch, S.; Shvets, O.; Simren, M.; Surdea-Blaga, T.; Tepes, B.; Tornblom, H.; Tutuian, R.; Verbeke, K.; Vogelsang, H.; Vranesic-Bender, D.; Wilder-Smith, C. | |
| Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease | 1-gen-2018 | Gaetani, E.; Zompo, F. D.; Marcantoni, M.; Gatto, I.; Giarretta, I.; Porfidia, A.; Scaldaferri, F.; Laterza, L.; Lopetuso, L.; Gasbarrini, A.; Pola, R. | |
| Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study | 1-gen-2019 | Piscaglia, A. C.; Lopetuso, L. R.; Laterza, L.; Gerardi, V.; Sacchini, E.; Leoncini, E.; Boccia, S.; Stefanelli, M. L.; Gasbarrini, A.; Armuzzi, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista12787
- 3 Libro1
Data di pubblicazione
- In corso di stampa6
- 2020 - 20267344
- 2010 - 20194109
- 2000 - 20091063
- 1990 - 1999221
- 1980 - 198943
- 1979 - 19792
Editore
- Dykinson1
- Luigi Pellegrini Editore1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...249
- JOURNAL OF CLINICAL MEDICINE147
- CANCERS120
- JOURNAL OF BIOLOGICAL REGULATORS ...112
- Q-TIMES WEBMAGAZINE109
- SCIENTIFIC REPORTS107
- INTERNATIONAL JOURNAL OF ENVIRONM...99
- PLOS ONE97
- APPLIED SCIENCES90
- JOURNAL OF ORTHOPAEDIC SURGERY AN...72
Keyword
- Humans336
- COVID-19332
- SARS-CoV-2178
- Male150
- Female141
- Italy104
- Middle Aged95
- Adult80
- Aged79
- inflammation67
Lingua
- eng9187
- ita1483
- fre41
- spa25
- und12
- pol7
- ger5
- por5
- afr1
- enm1
Accesso al fulltext
- no fulltext12788